Brain+ A/S announces amended terms for upcoming TO 3 warrant exercise
Brain+ A/S (Nasdaq First North: BRAINP) - This announcement constitutes inside information that Brain+ is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was provided by the contact person below for publication on 7 March 2024 · The previously announced minimum and maximum exercise price levels for Brain+ warrants of series TO 3 have been eliminated · With the amended terms, the exercise price for warrants of series TO 3 has been set at DKK 0.11 per new Brain+ share subscribed for, which represents a 33% discount to the closing